On August 10, 2023, Lisa Gill, an esteemed Analyst at JP Morgan, reaffirmed her Neutral rating on Lifestance Health Gr (NASDAQ:LFST) while increasing the price target from $9 to $10. As an analyst, Gill provides her expert projection of a stock’s future price, offering investors insight into where the asset may potentially settle. With a focus on the healthcare and consumer defensive sectors, Gill has established herself as a prominent figure on Wall Street, diligently covering numerous stocks. Since 2012, she has meticulously documented 294 price targets and ratings, showcasing her extensive knowledge and expertise in the field. Alongside LifeStance Health Gr, Gill also covers an impressive portfolio of 41 other stocks, boasting an impressive success rate of 63.29%.
LFST: Mixed Performance on August 10, 2023, with Impressive Earnings and Revenue Growth in the Healthcare Services Sector
LFST, a healthcare services company, experienced mixed performance on August 10, 2023. The stock opened at $8.11, slightly higher than the previous day’s closing price of $8.07. Throughout the trading day, LFST’s stock price fluctuated within a range of $7.98 to $8.36. The trading volume for the day was relatively low, with 38,745 shares being traded. LFST has a market capitalization of $3.4 billion. The company’s earnings growth has been impressive, with a growth rate of +42.22% in the previous year and +55.80% in the current year. LFST’s revenue growth in the last year was +28.77%. The company’s price-to-sales ratio is 2.04, and the price-to-book ratio is 2.33. LFST’s next reporting date is scheduled for November 7, 2023, when the company will release its financial results for the quarter. Analysts are forecasting an EPS loss of -$0.06 for the current quarter. In the previous year, LFST reported an annual revenue of $859.5 million, but incurred a net loss of -$215.6 million, resulting in a net profit margin of -25.08%. LFST operates in the health services sector, specifically in the medical/nursing services industry.
LFST Stock Performance on August 10, 2023: Analyst Forecasts and Consensus Ratings
LFST stock performances on August 10, 2023 were influenced by various factors, including analyst forecasts and consensus ratings. According to data from CNN Money, the 6 analysts offering 12-month price forecasts for Lifestance Health Group Inc had a median target of 9.75, with a high estimate of 10.00 and a low estimate of 9.00. This indicates that the analysts predicted a potential increase in the stock price by 18.61% from the last recorded price of 8.22.
Furthermore, the current consensus among 7 polled investment analysts was to hold stock in Lifestance Health Group Inc. This rating has remained steady since May, when it was downgraded from a buy rating.
In terms of financial performance, Lifestance Health Group Inc reported earnings per share of -$0.06 for the current quarter. This indicates that the company experienced a loss in earnings during this period. However, the company’s sales reached $251.5 million, which demonstrates a strong revenue generation.
It is important to note that the reported financial data is for the current quarter and the reporting date was November 7th. Therefore, the stock performances on August 10th may have been influenced by additional factors that were not captured in this data.
Overall, based on the analyst forecasts and consensus ratings, it appears that there was a positive sentiment towards LFST stock on August 10, 2023. However, investors should consider other factors and conduct further research before making any investment decisions.
The post JP Morgan Analyst Lisa Gill Reaffirms Neutral Rating on LifeStance Health Gr with Increased Price Target appeared first on Best Stocks.
